ICU Medical, Trading 7.4% Higher Following Earnings Beat (ICUI)
ICU Medical, (NASDAQ:ICUI) shares traded up 7.4% during trading on Tuesday following a better than expected earnings announcement, Analyst Ratings Network.com reports. The company traded as high as $63.89 and last traded at $62.19, with a volume of 265,315 shares. The stock had previously closed at $57.89.
The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.04. The company had revenue of $78.70 million for the quarter, compared to the consensus estimate of $74.13 million. During the same quarter in the previous year, the company posted $0.48 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis.
Separately, analysts at Raymond James upgraded shares of ICU Medical, from a “market perform” rating to an “outperform” rating in a research note on Tuesday. They now have a $67.00 price target on the stock. They noted that the move was a valuation call.
In other ICU Medical, news, Director George A. Lopez sold 12,750 shares of ICU Medical, stock on the open market in a transaction dated Monday, August 11th. The shares were sold at an average price of $57.85, for a total transaction of $737,587.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
The stock’s 50-day moving average is $59.7 and its 200-day moving average is $59.73. The company has a market cap of $953.3 million and a price-to-earnings ratio of 23.17.
ICU Medical, Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications.
Receive News & Ratings for ICU Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.